Traduction de «vasculaire » (Français → Anglais) :

This concept is primitive because within clinical practice it is used in different contexts to refer to both arteries and veins of the periphery or exclusively of peripheral arteries and sometimes to describe just occlusive disease of the peripheral

Retinal vascular disorder

Angiohaemophilia Factor VIII deficiency with vascular defect Vascular haemophilia

Cardiovascular:involvement NEC, in Chagas' disease (chronic) (B57.2+) | lesions of pinta [carate] (A67.2+)

arteriolosclerosis arteriosclerosis arteriosclerotic vascular disease atheroma degeneration:arterial | arteriovascular | vascular | endarteritis deformans or obliterans senile:arteritis | endarteritis

Changes in retinal vascular appearance Retinal:micro-aneurysms | neovascularization | perivasculitis | varices | vascular sheathing | vasculitis | Retinopathy:NOS | background NOS | Coats | exudative | hypertensive

Definition: Vascular dementia is the result of infarction of the brain due to vascular disease, including hypertensive cerebrovascular disease. The infarcts are usually small but cumulative in their effect. Onset is usually in later life. | arteriosclerotic dementia

Definition: Usually develops rapidly after a succession of strokes from cerebrovascular thrombosis, embolism or haemorrhage. In rare cases, a single large infarction may be the cause.

Ischemic bowel disease

...d device of immunosuppresssive agent Pharmacotherapy (local), pulmonary artery percutaneous injection approach using thrombolytic agent Pharmacotherapy (local), pulmonary artery percutaneous injection approach using antithrombotic agent Pharmacotherapy (local), pulmonary artery percutaneous injection approach using pharmacological agent NEC Pharmacotherapy (local), pulmonary artery percutaneous infusion approach using thrombolytic agent Pharmacotherapy (local), pulmonary artery percutaneous infusion approach using antithrombotic agent Pharmacotherapy (local), pulmonary artery percutaneous infusion approach using pharmacological agent NEC Occlusion, pulmonary artery percutaneous transluminal approach and ...[+++]vascular [nitinol mesh] plug Dilation, pulmonary vein using percutaneous transluminal approach [e.g. endovascular] and balloon dilator Dilation, pulmonary vein using percutaneous transluminal approach [e.g. endovascular] and stent Dilation, pulmonary vein using open approach and balloon dilator Dilation, pulmonary vein using open approach and stent Occlusion, pulmonary vein using percutaneous transluminal approach and vascular [nitinol mesh] plug Dilation, carotid artery using percutaneous transluminal approach and dilating device NEC Occlusion, carotid artery using percutaneous transluminal arterial approach using vascular [nitinol mesh] plug Bypass, carotid artery using autograft bypass terminating in upper limb artery [e.g. carotid-brachial] Occlusion, brachiocephalic arteries percutaneous transluminal approach and vascular [nitinol mesh] plug Dilation, subclavian artery using percutaneous transluminal approach and dilating device NEC Occlusion, subclavian artery percutaneous transluminal approach and vascular [nitinol mesh] plug Bypass, subclavian artery using autograft bypass terminating in artery of arm Bypass, subclavian artery using synthetic material bypass terminating in artery of arm Dilation, internal mammary artery using percutaneous transluminal approach and dilating device NEC Occlusion, internal mammary artery pe ...

21 Pulmonary embolus 52 Suicide 22 Cerebrovascular accident 53 Therapy ceased for any other reason 24 Hemorrhage from graft site—specify 54 Alcohol abuse 25 Hemorrhage from vascular access or dialysis circuit 26 Hemorrhage from ruptured vascular aneurysm (not code 22 or 23) 27 Hemorrhage from surgery (not codes 23 to 26)—specify ACCIDENT 28 Other hemorrhage (not codes 23 to 27) 81 Accident related to treatment 55 Vascular thrombosis 82 Accident unrelated to treatment 56 Pulmonary vein stenosis 57 Stent/balloon complication MISCELLANEOUS INFECTIONS 30 Hypertension

(pediatric only) 55 Drash syndrome 19 Glomerulonephritis, histologically examined—specify 58 Posterior urethral valves 73 Polyarteritis 59 Hereditary nephropathy, other—specify 74 Wegener’s granulomatosis 60 Congenital renal hypoplasia—specify 84 Lupus erythematosus 61 Oligomeganephronic hypoplasia 85 Henoch-Schonlein purpura 62 Segmental renal hypoplasia (Ask-Upmark kidney) 86 Goodpasture’s syndrome 63 Congenital renal dysplasia with or without urinary tract 87 Scleroderma malformation 88 Hemolytic uremic syndrome (Moschowitz syndrome) 66 Syndrome of agenesis of abdominal muscles (prune belly syndrome)

...l), intracranial vessels, elution from implanted device, using immunosuppressive agent Occlusion, intracranial vessels percutaneous transluminal approach using vascular [nitinol mesh] plug Occlusion, intracranial vessels open craniotomy flap approach using device NEC Occlusion, other vessels of head, neck and spine NEC endoscopic per orifice approach using clips Occlusion, other vessels of head, neck and spine NEC endoscopic per orifice approach using device NEC Occlusion, other vessels of head, neck and spine NEC percutaneous transluminal approach using vascular [nitinol ...[+++]mesh] plug Occlusion, thoracic vessels NEC percutaneous transluminal approach using vascular [nitinol mesh] plug Repair, thoracic vessels NEC using open approach with xenograft Pharmacotherapy (local), abdominal arteries NEC, percutaneous injection approach using thrombolytic agent Pharmacotherapy (local), abdominal arteries NEC, percutaneous infusion approach of thrombolytic agent Pharmacotherapy (local), abdominal arteries NEC, elution from implanted device, using plant alkaloids and other natural products Pharmacotherapy (local), abdominal arteries NEC, elution from implanted device, using immunosuppressive agent Dilation, abdominal arteries NEC using percutaneous transluminal approach and dilating device NEC Occlusion, abdominal arteries NEC percutaneous transluminal approach using vascular [nitinol mesh] plug Extraction, abdominal arteries NEC percutaneous transluminal approach using xenograft using laser Extraction, abdominal arteries NEC percutaneous transluminal approach using xenograft using atherectomy device (e.g. transluminal extractor catheter, rotoablator) Extraction, abdominal arteries NEC percutaneous transluminal approach using xenograft using device NEC Extraction, abdominal arteries NEC percutaneous transluminal approach using xenograft using laser with stent insertion Extraction, abdominal arteries NEC percutaneous transluminal approach using xenograft using atherectomy device with stent insertion Extraction, abdominal arteries NEC, open approach using xenograft using laser Extraction, abdominal arteries NEC open approach u ...